Pharmaceuticals
Indian pharmaceutical market to reach $56 billion in 2020

Indian pharmaceutical market to reach $56 billion in 2020

New Delhi: Driven by the country’s growing economy and population income, the Indian pharmaceutical market will increase significantly from approximately $21 billion in 2013 to $56 billion in 2020, at a compound annual growth rate (CAGR) of 15%, forecasts research and consulting firm, Research & Markets. more

Humira approved in Japan for treatment of Hidradenitis Suppurativa

Humira approved in Japan for treatment of Hidradenitis Suppurativa

New Delhi: AbbVie, a research-based global biopharmaceutical company headquartered in US, and Eisai, a leading global research & development-based pharmaceutical company headquartered in Japan, on Thursday announced that they have received approval for an additional indication of Humira (generic name: adalimumab), a fully human anti-TNF-alpha monoclonal antibody, for the treatment of hidradenitis suppurativa (HS). more

ICMR to test efficacy of two medicines for tackling drug-resistant TB

ICMR to test efficacy of two medicines for tackling drug-resistant TB

New Delhi: The Indian Council of Medical Research (ICMR) is planning to test the efficacy of two medicines — Metformin and Bedaquiline Delaminate — for tackling the drug-resistant tuberculosis. more

Novartis fined $49 million for bribing doctors to prescribe its drugs

Novartis fined $49 million for bribing doctors to prescribe its drugs

Seoul: Swiss pharmaceutical company Novartis has been fined 55.1 billion won ($48.80 million) by the South Korean government for bribing doctors to prescribe its drugs. The government has also suspended insurance coverage for Novartis’ nine medicines for six months. more

It may soon become mandatory for doctors to prescribe generic drugs

It may soon become mandatory for doctors to prescribe generic drugs

New Delhi: The government is preparing to launch a Uniform Code for Pharmaceutical Marketing Practices (UCPMP), which will mandate doctors to prescribe generic drugs rather than more expensive branded ones. more

US FDA approves two hepatitis C drugs for paediatric patients

US FDA approves two hepatitis C drugs for paediatric patients

Washington: The US Food and Drug Administration on Friday approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults. more

US FDA approves Xermelo for carcinoid syndrome diarrhoea

US FDA approves Xermelo for carcinoid syndrome diarrhoea

Washington: The US Food and Drug Administration on Tuesday approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analogue (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhoea that SSA therapy alone has inadequately controlled. more

US FDA approves new psoriasis drug

US FDA approves new psoriasis drug

Washington: The US Food and Drug Administration on Wednesday approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. more

GSK restores manufacturing of Neosporin

GSK restores manufacturing of Neosporin

Mumbai: GlaxoSmithKline Pharmaceuticals Limited on Saturday announced that it has restored the manufacturing of Neosporin, an antibiotic used to treat minor wounds. more

Alliance of Doctors for Ethical Healthcare comes out in support of Whistleblower Paediatrician

Alliance of Doctors for Ethical Healthcare comes out in support of Whistleblower Paediatrician

New Delhi: The Alliance of Doctors for Ethical Healthcare (ADEH) on Wednesday said it is dismayed by the news that Dr more